| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |